Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anpac Bio-Medical Science ADR (ANPC)

Anpac Bio-Medical Science ADR (ANPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,234
  • Shares Outstanding, K 969
  • Annual Sales, $ 1,750 K
  • Annual Income, $ -14,770 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.56
  • Price/Sales 2.56
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.17
  • Most Recent Earnings $-0.16 on 12/19/22
  • Next Earnings Date 05/30/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.19 +4.30%
on 05/16/23
9.17 -52.34%
on 05/02/23
-0.19 (-4.17%)
since 04/19/23
3-Month
3.49 +25.22%
on 04/13/23
9.19 -52.46%
on 02/21/23
-4.90 (-52.86%)
since 02/17/23
52-Week
2.60 +68.08%
on 09/19/22
11.99 -63.55%
on 01/19/23
-1.53 (-25.91%)
since 05/19/22

Most Recent Stories

More News
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'

/PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China...

ANPC : 4.37 (-5.41%)
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022

/PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations...

ANPC : 4.37 (-5.41%)
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results

/PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations...

ANPC : 4.37 (-5.41%)
Fresh2 Reports Fiscal Year 2022 Annual Financial Results

/PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations...

ANPC : 4.37 (-5.41%)
AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering

/PRNewswire/-- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China focused on early...

ANPC : 4.37 (-5.41%)
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.

/PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China focused on early...

ANPC : 4.37 (-5.41%)
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract

/PRNewswire/ – AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company" (Nasdaq: ANPC), a company with operations in the United States and China...

ANPC : 4.37 (-5.41%)
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer

PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company...

ANPC : 4.37 (-5.41%)
AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees

PHILADELPHIA, July 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company...

ANPC : 4.37 (-5.41%)
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market

PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company...

ANPC : 4.37 (-5.41%)

Business Summary

AnPac Bio-Medical Science Co., Ltd. is a biotechnology company focused on early cancer screening and detection. AnPac Bio-Medical Science Co., Ltd. is based in China.

See More

Key Turning Points

3rd Resistance Point 5.00
2nd Resistance Point 4.82
1st Resistance Point 4.60
Last Price 4.37
1st Support Level 4.20
2nd Support Level 4.02
3rd Support Level 3.80

See More

52-Week High 11.99
Fibonacci 61.8% 8.40
Fibonacci 50% 7.30
Fibonacci 38.2% 6.19
Last Price 4.37
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar